Trends in In-Hospital Major Morbidity and Mortality After Total Joint Arthroplasty: United States 1998–2008

BACKGROUND:The use of total joint arthroplasties is increasing worldwide. In this work we aim to elucidate recent trends in demographics and perioperative outcomes of patients undergoing total hip (THA) or total knee arthroplasty (TKA). METHODS:Data from the US Nationwide Impatient Sample between 1998 and 2008 were gathered for primary THAs and TKAs. Trends in patient age, comorbidity burden, length of hospitalization, frequency of major perioperative complications, and in-hospital mortality were analyzed. In-hospital outcomes were reported as events per 1000 inpatient days to account for changes in length of hospitalization over time. Deyo index, discharge status, and the interaction effect of time and discharge status were included in the adjusted trend analysis for morbidity. RESULTS:Between 1998 and 2008, the average age of patients undergoing TKA and THA decreased by 2 to 3 years (P < 0.001). The average length of stay decreased by approximately 1 day over the time interval studied (P < 0.001). The percentage of patients being discharged home declined from 29.7% to 25.4% after TKA and from 29.3% to 24.2% after THA, in favor of dispositions to long- and short-term care facilities (P < 0.0001). Comorbidity burden as measured by the Deyo comorbidity index increased by 35% and 30% for TKA and THA patients, respectively (P < 0.0001). After TKA, there was an increase in the incidence of the following major complications: pulmonary embolism (coefficient estimate [CE] 0.069; 95% confidence interval [CI], 0.059–0.079; P < 0.0001), sepsis (CE 0.034; 95% CI, 0.014–0.054; P = 0.001), nonmyocardial infarction cardiac complications (CE 0.038; 95% CI, 0.035–0.041; P < 0.0001), and pneumonia (CE 0.039; 95% CI, 0.031–0.047; P < 0.0001). After THA, there was an increase in the incidence of the following major complications: pulmonary embolism (CE 0.031; 95% CI, 0.012–0.049; P = 0.001), sepsis (CE 0.060; 95% CI, 0.039–0.081; P < 0.0001), nonmyocardial infarction cardiac complications (CE 0.040; 95% CI, 0.036–0.043; P < 0.0001), and pneumonia (CE 0.039; 95% CI, 0.029–0.048). In-hospital mortality declined after both TKA (CE −0.059; 95% CI, −0.077 to −0.040; P < 0.0001) and THA (CE −0.068; 95% CI, −0.086 to −0.051; P < 0.0001). CONCLUSION:Between 1998 and 2008, trends show increases in several major in-hospital complications after THA and TKA, including pulmonary embolism, sepsis, nonmyocardial infarction cardiac complications, and pneumonia. Despite the increase in complications, declining in-hospital mortality was noted over this period.

[1]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[2]  P. Araoz,et al.  The effect of helical computed tomography on diagnostic and treatment strategies in patients with suspected pulmonary embolism. , 2004, The American journal of medicine.

[3]  O. Baser,et al.  Impact of postoperative venous thromboembolism on Medicare recipients undergoing total hip replacement or total knee replacement surgery. , 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[4]  Steven Woloshin,et al.  Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. , 2010, Archives of internal medicine.

[5]  R. Laskin,et al.  Trends in demographics, comorbidity profiles, in-hospital complications and mortality associated with primary knee arthroplasty. , 2009, The Journal of arthroplasty.

[6]  O. Baser,et al.  Clinical and cost outcomes of venous thromboembolism in Medicare patients undergoing total hip replacement or total knee replacement surgery , 2011, Current medical research and opinion.

[7]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[8]  A. Gonzalez Della Valle,et al.  Trends in mortality, complications, and demographics for primary hip arthroplasty in the United States , 2009, International Orthopaedics.

[9]  A. Forster,et al.  Effect of &bgr;-blocker Prescription on the Incidence of Postoperative Myocardial Infarction after Hip and Knee Arthroplasty , 2009, Anesthesiology.

[10]  J. Ely,et al.  An Introduction to Time-Trend Analysis , 1997, Infection Control &#x0026; Hospital Epidemiology.

[11]  D. Schroeder,et al.  Frequency of Myocardial Infarction, Pulmonary Embolism, Deep Venous Thrombosis, and Death following Primary Hip or Knee Arthroplasty , 2002, Anesthesiology.

[12]  P. Devereaux,et al.  Incidence and timing of myocardial infarction after total joint arthroplasty. , 2006, The Journal of arthroplasty.

[13]  J. Parvizi,et al.  In hospital complications after total joint arthroplasty. , 2008, The Journal of arthroplasty.

[14]  G. Agnelli,et al.  Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. , 2007, The Journal of bone and joint surgery. British volume.

[15]  J. Parvizi,et al.  Total joint arthroplasty: When do fatal or near-fatal complications occur? , 2006, The Journal of bone and joint surgery. American volume.

[16]  A. Forster,et al.  Effect of -blocker Prescription on the Incidence of Postoperative Myocardial Infarction after Hip and Knee , 2009 .

[17]  L I Iezzoni,et al.  Identifying Complications of Care Using Administrative Data , 1994, Medical care.

[18]  E. Fishman,et al.  CT pulmonary angiography is the first-line imaging test for acute pulmonary embolism: a survey of US clinicians. , 2006, Academic radiology.

[19]  T. Sculco,et al.  In-hospital Complications and Mortality of Unilateral, Bilateral, and Revision TKA: Based on an estimate of 4,159,661 Discharges , 2008, Clinical orthopaedics and related research.

[20]  Eric B. Smith,et al.  The Rise in the Incidence of Pulmonary Embolus after Joint Arthroplasty: Is Modern Imaging to Blame? , 2007, Clinical orthopaedics and related research.